drugset / Trial / NCT02153866
The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine
Phase 4
Unknown
2800 enrolled
Sichuan Center for Disease Control and Prevention
China National Biotec Group Company Limited · collab
RandomizedFactorialOpen-labelPrevention
Summary
Nowadays these are some vaccines being vaccinated simultaneously, and a doubt is aroused if the safety and immunogenicity are same between inoculating several vaccines simultaneously and inoculating individually. So we carry out this study. The purpose of this study is to evaluate the difference of safety and immunogenicity on vaccinating rotavirus vaccine simultaneously with measles-rubella vaccine(MR) or measles-mumps-rubella vaccine(MMR) compared to vaccinating rotavirus vaccine, MR or MMR individually.
Timeline
- Start
- 2013-12
- Primary completion
- 2014-05
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Measles-Mumps-Rubella Vaccine | Vaccine | 0.5 ml | Subcutaneous |
| Subject | Measles-Rubella vaccine | Vaccine | 0.5 ml | Subcutaneous |
| Subject | Rotarix | Vaccine | 3 ml | Oral |